Horizon Therapeutics Public (NASDAQ:HZNP) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a research note issued to investors on Tuesday. The firm issued a strong-buy rating on the biopharmaceutical company’s stock. Separately, Jefferies Financial Group cut Horizon Therapeutics Public from a buy rating to a hold rating in a report on Friday, September […]

Related Keywords

,Horizon Therapeutics Public Limited Company ,Global Retirement Partners ,Xponance Inc ,Quent Capital ,Ieq Capital ,Vanguard Personalized Indexing Management ,Jefferies Financial Group ,Horizon Therapeutics Public ,Free Report ,Therapeutics Public ,Get Free Report ,Personalized Indexing Management ,Retirement Partners ,Therapeutics Public Limited Company ,Horizon Therapeutics Public Daily ,Nasdaq Hznp ,Hznp ,Medical ,44047t10 ,Initiated Coverage ,Stocknews Com ,